PATRICIA MARTINO: Open Payments
NPI 1689699175 · WARWICK, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$494 in 20 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $494
Food & beverage: $494
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $187 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $80 |
| GlaxoSmithKline, LLC. | 3 | $59 |
| Edwards Lifesciences Corporation | 1 | $46 |
| Exact Sciences Corporation | 1 | $32 |
| Lundbeck LLC | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $27 |
| PFIZER INC. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: VRAYLAR, UBRELVY, SHINGRIX, REXULTI, Cologuard Collection Kit, NURTEC ODT, TRELEGY ELLIPTA, QULIPTA.
Industry payments across RI — which companies pay providers there.
